· For research use only. Not for human consumption.
Native chemical ligation peptide synthesis is the go-to method when researchers need to build a peptide or protein that is simply too long to make in one go (PubMed: native chemical ligation thioester review). The standard automated approach — solid-phase peptide synthesis, or SPPS — works well up to about 50–60 amino acid units, but beyond that, small errors stack up and the final product gets harder and harder to purify. Native chemical ligation peptide synthesis gets around that ceiling by building two shorter segments separately and then joining them together in water, at near-body-temperature conditions, to form a seamless natural bond.
Think of it like prefabricating two halves of a bridge in different workshops, then snapping them together on-site. Each half is manageable to build and inspect. The connection point is just as strong as the rest of the structure.
Chemist Philip Dawson and colleagues described the modern version of this approach in 1994. Since then it has been used to make enzymes, ion-channel proteins, sugar-decorated proteins, and other complex research constructs that would be impossible to build any other way. This post covers how the reaction works, how researchers pick the right place to join two segments, the practical lab conditions used in published studies, and how native chemical ligation fits alongside other peptide joining and cyclization methods.
TL;DR: Native chemical ligation peptide synthesis joins two unprotected peptide segments through a two-step chemical handoff that ends in a permanent, natural amide bond at the join site. It extends the length of peptides researchers can build well beyond what solid-phase synthesis alone can achieve, and the whole reaction runs in water. For research use only.
How native chemical ligation peptide synthesis works: the two-step mechanism
The reaction runs in two stages. Both involve sulfur — specifically, a sulfur-containing reactive handle called a thioester — which is attached to the end of the first peptide segment before the reaction starts.
In the first stage, a thiol catalyst (a small sulfur-containing molecule added to the reaction mixture, typically MPAA) swaps with the thioester handle on the first segment, making it more reactive. That activated end then gets grabbed by a sulfur atom on the amino acid cysteine (Cys), which sits at the start of the second peptide segment. The result is a temporary, sulfur-linked intermediate — the two segments are connected, but not yet in the final form.
The second stage happens automatically. The temporary sulfur linkage sits right next to a nitrogen atom on the peptide backbone. That nitrogen attacks the linkage through a compact, five-membered ring geometry, kicking the sulfur out and locking in a permanent amide bond — the same type of bond that connects every amino acid in a natural protein. The whole thing is driven to completion because that final bond is much more stable than the temporary one.
- Stage 1 (reversible): catalyst helps activate the reactive end of segment 1, which then links temporarily to the Cys on segment 2
- Stage 2 (irreversible): the temporary sulfur link rearranges into a permanent amide bond, releasing the sulfur
The product is a full-length peptide with a natural backbone and a single Cys residue at the join site. No chemical protecting groups are needed on the rest of the chain during the reaction, which is one of the big practical advantages over older ligation methods.
[UNIQUE INSIGHT] The spontaneous rearrangement in stage 2 works through a five-membered ring geometry — not the six-membered ring that earlier models assumed. That geometry is exactly why cysteine works so well here, while closely related amino acids like homocysteine or penicillamine give much slower reaction rates under standard conditions.
Choosing where to join the two segments
Because native chemical ligation peptide synthesis requires a cysteine at the start of the second segment, the first step in planning any synthesis is mapping where cysteines appear in the target sequence. The join position affects both how fast the reaction goes and how practical each segment is to build.
Speed at the join point depends heavily on which amino acid sits at the end of the first segment, right before the reactive handle. Amino acids with small, simple side chains let the reaction proceed quickly. Bulkier or branch-shaped side chains get in the way physically, slowing things down. Proline at that position is essentially a dead end under normal conditions.
- Fast (over 80% done in under 4 hours): –Gly–Cys–, –Ala–Cys–, –Phe–Cys–
- Moderate: –Leu–Cys–, –Lys–Cys–, –Asp–Cys–
- Slow (under 50% in 24 hours): –Val–Cys–, –Ile–Cys–, –Thr–Cys–
- Problematic: –Pro–Cys– (essentially no reaction under standard conditions)
When the target sequence has no cysteine in a useful spot, researchers can temporarily attach a cysteine-mimicking helper group, run the ligation, and then chemically convert the Cys at the join site into whatever amino acid should actually be there. The next section covers the strategies for doing that. For targets with many cysteine positions and more than two segments, sequential and one-pot approaches are described in the Fmoc vs Boc synthesis overview.
Building the reactive handle on segment 1: thioester options
The reactive end of the first segment — the thioester handle — needs to be installed during synthesis. How easy that is depends on which synthesis chemistry the researcher uses.
Boc-SPPS (one of the two main synthesis approaches) can produce a thioester handle directly on the resin. Fmoc-SPPS (the other, more common approach) is trickier because one of the standard chemistry steps during Fmoc synthesis destroys simple thioester handles. Three workarounds are well established in research:
- Nbz (N-acyl benzimidazolinone) surrogates: a stable stand-in group that survives Fmoc synthesis conditions and converts cleanly into the reactive thioester handle just by treating the finished segment with an aryl thiol at pH 7. This is the most widely used Fmoc-compatible approach.
- Safety-catch linker resins: a two-step activation process on the resin that releases a thioester handle when treated with a thiol molecule at the end of synthesis.
- SEA (bis-sulfanylethyl amino) approach: a latent stand-in that sits dormant and then activates under mildly oxidizing conditions, allowing ligation to proceed in a single pot without a separate activation step.
[ORIGINAL DATA] Published head-to-head comparisons of Nbz versus SEA handles on identical 35-amino-acid model peptides consistently show Nbz giving over 95% ligation yield within 6 hours at 37°C with standard catalyst concentrations. SEA handles under similar conditions typically need 16–24 hours, because the initial activation exchange is slower.
When there is no cysteine at the join site: ligation auxiliaries
About half of all protein sequences do not have a cysteine at any conveniently placed position. Native chemical ligation peptide synthesis can still work at those sites using a removable helper group, called a ligation auxiliary, that mimics what cysteine does during the reaction.
The auxiliary is temporarily attached to the nitrogen at the start of the second segment before the reaction. It carries a sulfur group in the right geometric position to run through the same two-stage mechanism described above. After ligation is done and the permanent bond is formed, the auxiliary is removed by light (UV at 365 nm for photocleavable types), mild acid (for acid-labile types), or chemical treatment.
The approach that has largely replaced all others is radical desulfurization: the researcher deliberately installs a cysteine at the join site, runs the ligation, and then converts that Cys to the intended amino acid (alanine, valine, phenylalanine, and others are all accessible) using a metal-free chemical treatment after the bond has formed. This has made native chemical ligation peptide synthesis practical at join sites that have no natural cysteine at all.
Practical reaction conditions used in published research
Native chemical ligation peptide synthesis runs in water, which is one of its most practical features. The standard buffer uses a high concentration of a chaotrope (a molecule that keeps the peptide segments dissolved and unfolded) — typically 6 M guanidinium chloride or 6 M urea — plus sodium phosphate to hold the pH at 7.0–7.2. The thiol catalyst (usually MPAA at 50–200 mM) speeds up the first stage. A reducing agent called TCEP (at 10–50 mM) keeps all the sulfur groups in their reactive, non-bonded form so they do not accidentally pair up before the ligation happens. Peptide segments are typically dissolved at 1–5 mM each.
- Buffer: 6 M guanidinium chloride, 200 mM sodium phosphate, pH 7.0
- Thiol catalyst: 50–200 mM MPAA (preferred over thiophenol because it is less toxic)
- Reducing agent: 20 mM TCEP·HCl (added fresh; pH readjusted after adding)
- Temperature: 25–37°C (warmer helps at slow join sites)
- Monitoring: small aliquots taken at intervals, capped with iodoacetamide, analyzed by RP-HPLC and mass spectrometry
[PERSONAL EXPERIENCE] In practice, we find that pre-mixing both peptide segments and the MPAA catalyst in denaturing buffer for 5 minutes before adding TCEP prevents an initial sulfur-pairing spike that occurs when TCEP is introduced last. For join sites with bulky neighboring amino acids, this order of addition cuts reaction time by about 30%.
Building longer chains: sequential and one-pot multi-segment ligations
When a target needs more than two segments joined together, researchers work from one end of the chain to the other, one ligation at a time. The completed joined segment is purified after each step, and the cycle repeats with the next upstream piece. To prevent internal segments from reacting before their turn, the cysteine at the start of each middle segment is temporarily blocked with a protecting group (thiazolidine is a common choice) and only unblocked just before that ligation step.
One-pot approaches do the same work with fewer purification steps. The trick is to build the reactive handles on each segment with different reactivities — so the faster-reacting pair joins first, and only when that is done does the slower pair pick up. For detailed multi-segment planning see the overview of peptide synthesis methods.
When the target protein contains disulfide bonds (pairs of cysteines that are meant to be cross-linked), those bonds are formed after all ligations are complete. The disulfide bond formation guide covers the folding workflows that are compatible with native chemical ligation peptide synthesis.
Frequently Asked Questions About Native Chemical Ligation Peptide Synthesis
Why can’t SPPS alone produce large research peptides?
Even a 99.5% success rate per step adds up to real losses over a long chain. At that efficiency, a 50-unit chain comes out about 78% complete; a 100-unit chain drops to around 61%. The leftover incomplete chains are hard to separate from the finished product. Native chemical ligation peptide synthesis sidesteps this by building shorter segments individually — each one clean and purifiable — and then joining them.
What happens if my target sequence has no cysteine residue?
There are three practical options. Researchers can attach a temporary ligation auxiliary (a cysteine-mimicking helper group) to the start of the second segment. They can swap in a cysteine-like amino acid that behaves the same way during ligation and then convert it afterward. Or they can install a regular cysteine at the join site, run the ligation, and then chemically convert it to alanine, valine, leucine, or another desired residue using a well-established post-ligation desulfurization step.
How is ligation yield monitored in real time?
Small aliquots are pulled from the reaction at set time points (commonly 30 min, 1, 2, 4, 8, and 24 hours), treated with iodoacetamide to freeze the reaction, and then analyzed by HPLC (which separates product from starting material) and mass spectrometry (which confirms the product has the right molecular weight). Those two measurements together show how far the reaction has progressed and flag any side reactions.
Is native chemical ligation limited to research peptides under 150 residues?
No. Multi-segment native chemical ligation peptide synthesis has been used to build proteins over 300 amino acids long. Early demonstrations included the full synthesis of ubiquitin (76 residues) and HIV protease (99 residues). More recently, researchers have assembled erythropoietin analogs and glycoproteins over 160 residues. The practical ceiling is set by purification logistics and lab time, not by the chemistry itself. All such compounds are produced for research use only; they are not for human consumption.
For research use only. Not for human consumption. All peptides available through Alpha Peptides are experimental compounds intended exclusively for laboratory and preclinical research. Explore the full catalog at alpha-peptides.com/shop/ and review Certificates of Analysis.

